Cargando…
Strong radioprotective FGF1 signaling down-regulates proliferative and metastatic capabilities of the angiosarcoma cell line, ISOS-1, through the dual inhibition of EGFR and VEGFR pathways
BACKGROUND AND PURPOSE: Angiosarcoma is associated with a poor prognosis and is treated with radiotherapy. Although FGF1 is a potential radioprotector, the influence of FGF1 on the malignancy of angiosarcoma remains unknown. MATERIALS AND METHODS: Highly stable FGF1 mutants, which exhibit stronger m...
Autores principales: | Miura, Taichi, Fujita, Mayumi, Kawano, Mitsuko, Imadome, Kaori, Yasuda, Takeshi, Nishihara, Shoko, Imamura, Toru, Masuzawa, Mikio, Imai, Takashi, Nakayama, Fumiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862641/ https://www.ncbi.nlm.nih.gov/pubmed/29594234 http://dx.doi.org/10.1016/j.ctro.2017.10.006 |
Ejemplares similares
-
The FGF1/CPP-C chimera protein protects against intestinal adverse effects of C-ion radiotherapy without exacerbating pancreatic carcinoma
por: Kawano, Mitsuko, et al.
Publicado: (2018) -
FGF18 signaling in the hair cycle resting phase determines radioresistance of hair follicles by arresting hair cycling
por: Kawano, Mitsuko, et al.
Publicado: (2016) -
Combined VEGFR and MAPK pathway inhibition in angiosarcoma
por: Wagner, Michael J., et al.
Publicado: (2021) -
Radioprotective and Radiomitigative Effects of Melatonin in Tissues with Different Proliferative Activity
por: Abdullaev, Serazhutdin A., et al.
Publicado: (2021) -
Establishment and characterization of a novel lymphangiosarcoma cell line (MO-LAS) compared with the hemangiosarcoma cell line (ISO-HAS)
por: Masuzawa, Mikio, et al.
Publicado: (2012)